During EBV infection, the increased CD8+CD28−CD57+ T-cells upregulate PD-1 expression, increase IFN-γ release, inhibit the conversion of EBV-infected B-cells to memory cells and induce the development of MS (Cencioni et al., 2017). Here, CD8A is linked to myeloid sarcoma.